Cargando…
Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high‐risk Chinese individuals
Identification of deleterious variants in hereditary breast and ovarian cancer (HBOC) susceptibility genes allows for increased clinical surveillance and early detection, and could predict the response to poly (ADP‐ribose) polymerase (PARP) inhibitor in patients with advanced ovarian carcinomas. To...
Autores principales: | Shao, Di, Cheng, Shaomin, Guo, Fengming, Zhu, Changbin, Yuan, Yuying, Hu, Kunling, Wang, Zhe, Meng, Xuan, Jin, Xin, Xiong, Yun, Chai, Xianghua, Li, Hong, Zhang, Yu, Zhang, Hongyun, Liu, Jihong, Ye, Mingzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004523/ https://www.ncbi.nlm.nih.gov/pubmed/31742824 http://dx.doi.org/10.1111/cas.14242 |
Ejemplares similares
-
Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis
por: Yoshida, Reiko
Publicado: (2020) -
Editorial: HBOC and high-risk screening: up-to-date
por: Kataoka, Masako
Publicado: (2021) -
Cancer predisposition genes: molecular mechanisms and clinical impact on personalized cancer care: examples of Lynch and HBOC syndromes
por: Wang, Qing
Publicado: (2016) -
New Applications of HBOC-201: A 25-Year Review of the Literature
por: Cao, Min, et al.
Publicado: (2021) -
Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan
por: Arai, Masami, et al.
Publicado: (2017)